Substance misuse in depression and bipolar disorder: a review of psychological interventions and considerations for clinical practice

Richardson, T.

doi:10.1080/17523281.2012.680485

Cited by 7 publications

(2 citation statements)

References 120 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Relatively few trials have focused on the treatment of co-existing alcohol misuse and depression (e.g., Kay-Lambkin, Baker, Lewin, & Carr, 2009;Markowitz, Kocsis, Christos, Bleiberg, & Carlin, 2008;Satre, Delucchi, Lichtmacher, Sterling, & Weisner, 2013) and, as several reviews have noted, further research in this area is needed (e.g., Baker, Thornton, Hiles, Hides, & Lubman, 2012;Hides, Samet, & Lubman, 2010;Kelly, Daley, & Douaihy, 2012;Richardson, 2012;Tiet & Mausbach, 2007). There have also been calls for more targeted approaches to pharmacological treatments for comorbid substance use and mood disorders, which go beyond evidence based on single disorders (Pettinati, O'Brien, & Dundon, 2013).…”

Section: Introductionmentioning

confidence: 99%

Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months

Baker

Kavanagh

Kay‐Lambkin

et al. 2014

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

Integrated psychological treatment addressing co-existing alcohol misuse and depression has not been compared with single-focused treatment. This trial evaluates changes over 36 months following randomization of 284 outpatients to one of four motivational interviewing and cognitive-behavior therapy (MICBT) based interventions: (1) brief integrated intervention (BI); or BI plus 9 further sessions with (2) an integrated-, (3) alcohol-, or (4) depression-focus. Outcome measures included changes in alcohol consumption, depression (BDI-II: Beck Depression Inventory) and functioning (GAF: Global Assessment of Functioning), with average improvements from baseline of 21.8 drinks per week, 12.6 BDI-II units and 8.2 GAF units. Longer interventions tended to be more effective in reducing depression and improving functioning in the long-term, and in improving alcohol consumption in the short-term. Integrated treatment was at least as good as single-focused MICBT. Alcohol-focused treatment was as effective as depression-focused treatment at reducing depression and more effective in reducing alcohol misuse. The best approach seems to be an initial focus on both conditions followed by additional integrated- or alcohol-focused sessions.

show abstract

Section: Introductionmentioning

confidence: 99%

Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months

Baker

Kavanagh

Kay‐Lambkin

et al. 2014

Journal of Substance Abuse Treatment

View full text Add to dashboard Cite

show abstract

“…Regardless, such patients merit special clinical consideration (Richardson, 2013). Cannabis is the most prevalent drug used by the under-18s (National Treatment Agency., 2012) and during this critical period of development (Paus et al, 2008) services should be especially aware of and responsive to the problems that cannabis use can cause for adolescent populations (NTA., 2012).…”

Section: Implications For Clinical and Research Practicementioning

confidence: 99%

Cannabis use and mania symptoms: A systematic review and meta-analysis

Gibbs

Winsper

Marwaha

et al. 2015

Journal of Affective Disorders

176

121

View full text Add to dashboard Cite

(2015) Cannabis use and mania symptoms : a systematic review and meta-analysis. Journal of Affective Disorders, Volume 171 . pp. 39-47. Permanent WRAP url:http://wrap.warwick.ac.uk/64733 Copyright and reuse:The Warwick Research Archive Portal (WRAP) makes this work of researchers of the University of Warwick available open access under the following conditions. Copyright © and all moral rights to the version of the paper presented here belong to the individual author(s) and/or other copyright owners. To the extent reasonable and practicable the material made available in WRAP has been checked for eligibility before being made available.Copies of full items can be used for personal research or study, educational, or not-forprofit purposes without prior permission or charge. Provided that the authors, title and full bibliographic details are credited, a hyperlink and/or URL is given for the original metadata page and the content is not changed in any way. Publisher statement: NOTICE: this is the author's version of a work that was accepted for publication in Journal of Affective Disorders. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in http://dx.doi.org/10.1016/j.jad.2014.09.016 A note on versions:The version presented here may differ from the published version or, version of record, if you wish to cite this item you are advised to consult the publisher's version. Please see the 'permanent WRAP url' above for details on accessing the published version and note that access may require a subscription. 2 Background: Whilst cannabis use appears to be a causal risk factor for the development of schizophrenia-related psychosis, associations with mania remain relatively unknown. This review aimed to examine the impact of cannabis use on the incidence of manic symptoms and on their occurrence in those with pre-existing bipolar disorder Methods: A systematic review of the scientific literature using the PRISMA guidelines.PsychINFO, Cochrane, Scopus, Embase and MEDLINE databases were searched for prospective studies.Results: Six articles met inclusion criteria. These sampled 2,391 individuals who had experienced mania symptoms. The mean length of follow up was 3.9 years.Studies support an association between cannabis use and the exacerbation of manic symptoms in those with previously diagnosed bipolar disorder. Furthermore, a meta-analysis of two studies suggests that cannabis use is associated with an approximately 3-fold (Odds Ratio: 2.97; 95% CI: 1.80 to 4.90) increased risk for the new onset of manic symptoms. Limitations:We were only able to identify a small number of studies of variable quality, thus our conclusions remain preliminary. Conclusions:Our findings whilst tentative, suggest that cannabis use may worsen the occurrence of manic symptoms i...

show abstract

Addiction and Mental Health

HUXLEY

2017

Addiction

View full text Add to dashboard Cite

Substance misuse in depression and bipolar disorder: a review of psychological interventions and considerations for clinical practice

Cited by 7 publications

References 120 publications

Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months

Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months

Cannabis use and mania symptoms: A systematic review and meta-analysis

Addiction and Mental Health

Contact Info

Product

Resources

About